Works matching IS 17921074 AND DT 2022 AND VI 23 AND IP 5

Results: 30

Tyrosinase suppresses vasculogenic mimicry in human melanoma cells.

Published in:

Oncology Letters, 2022, v. 23, n. 5, p. 1, doi. 10.3892/ol.2022.13289

By:

HIROKI KAMO;
RYOTA KAWAHARA;
SIRO SIMIZU

Publication type:

Article

Characteristics and outcomes of cancer patients who develop pulmonary embolism: A cross-sectional study.

Published in:

Oncology Letters, 2022, v. 23, n. 5, p. 1, doi. 10.3892/ol.2022.13288

By:

CHLAPOUTAKIS, SERAFEIM;
GEORGAKOPOULOU, VASILIKI EPAMEINONDAS;
TRAKAS, NIKOLAOS;
KOUVELOS, GEORGIOS;
PAPALEXIS, PETROS;
DAMASKOS, CHRISTOS;
SKLAPANI, PAGONA;
GRIVAS, ANASTASIOS;
GOUVERIS, PANAGIOTIS;
TRYFONOPOULOS, DIMITRIOS;
TZOVARAS, ALEXANDROS;
ARDAVANIS-LOUKERIS, GERASIMOS;
GROUZI, ELISSAVET;
SPANDIDOS, DEMETRIOS A.;
MATSAGKAS, MILTIADIS

Publication type:

Article

High postoperative carcinoembryonic antigen as an indicator of high-risk stage II colon cancer.

Published in:

Oncology Letters, 2022, v. 23, n. 5, p. 1, doi. 10.3892/ol.2022.13287

By:

YOSHIHIRO MORIMOTO;
HIDEKAZU TAKAHASHI;
ASAMI ARITA;
HIROAKI ITAKURA;
MAKOTO FUJII;
YUKI SEKIDO;
TSUYOSHI HATA;
SHIKI FUJINO;
TAKAYUKI OGINO;
NORIKATSU MIYOSHI;
MAMORU UEMURA;
CHU MATSUDA;
HIROFUMI YAMAMOTO;
TSUNEKAZU MIZUSHIMA;
YUICHIRO DOKI;
HIDETOSHI EGUCHI

Publication type:

Article

CD155 expression and its clinical significance in non-small cell lung cancer.

Published in:

Oncology Letters, 2022, v. 23, n. 5, p. 1, doi. 10.3892/ol.2022.13286

By:

RINTARO OYAMA;
MASATOSHI KANAYAMA;
MASATAKA MORI;
HIROKI MATSUMIYA;
AKIHIRO TAIRA;
SHINJI SHINOHARA;
MASARU TAKENAKA;
KAZUE YONEDA;
KOJI KURODA;
FUMIHIRO TANAKA

Publication type:

Article

Immunological effect of tyrosine kinase inhibitors on the tumor immune environment in non-small cell lung cancer (Review).

Published in:

Oncology Letters, 2022, v. 23, n. 5, p. 1, doi. 10.3892/ol.2022.13285

By:

LI JIANG;
JIYAN LIU

Publication type:

Article

Tonsillar swabs and sputum predict SLPI- and AnxA2 expression in tonsils: A prospective study on smoking dependent SLPI- and AnxA2-expression, and tonsillar HPV infection.

Published in:

Oncology Letters, 2022, v. 23, n. 5, p. 1, doi. 10.3892/ol.2022.13284

By:

QUABIUS, ELGAR SUSANNE;
HEINRICHS, ALESSA;
KÜHNEL, ANDRÉ;
LAUDIEN, MARTIN;
HOPPE, FLORIAN;
MLYNSKI, ROBERT;
AMBROSCH, PETRA;
HOFFMANN, MARKUS

Publication type:

Article

AK4P1 is a cancer-promoting pseudogene in pancreatic adenocarcinoma cells whose transcripts can be transmitted by exosomes.

Published in:

Oncology Letters, 2022, v. 23, n. 5, p. 1, doi. 10.3892/ol.2022.13283

By:

LING LI;
TAO DENG;
QIUYING ZHANG;
YANLONG YANG;
YANG LIU;
LEYONG YUAN;
MINGSHUI XIE

Publication type:

Article

miR-217-5p suppresses epithelial-mesenchymal transition and the NF-κB signaling pathway in breast cancer via targeting of metadherin.

Published in:

Oncology Letters, 2022, v. 23, n. 5, p. 1, doi. 10.3892/ol.2022.13282

By:

LIXIAN YANG;
SHUO LIU;
LIU YANG;
BIN XU;
MEIQI WANG;
XIANGSHUN KONG;
ZHENCHUAN SONG

Publication type:

Article

Carboxymethylated pachyman induces ferroptosis in ovarian cancer by suppressing NRF1/HO-1 signaling.

Published in:

Oncology Letters, 2022, v. 23, n. 5, p. 1, doi. 10.3892/ol.2022.13281

By:

TIANTIAN JING;
YANLI GUO;
YANQIU WEI

Publication type:

Article

GPAA1 promotes the proliferation, invasion and migration of hepatocellular carcinoma cells by binding to RNA-binding protein SF3B4.

Published in:

Oncology Letters, 2022, v. 23, n. 5, p. 1, doi. 10.3892/ol.2022.13280

By:

SONG GE;
QIANG ZHANG;
XIAOYONG YANG

Publication type:

Article

Regulation of ROCK1/2 by long non-coding RNAs and circular RNAs in different cancer types (Review).

Published in:

Oncology Letters, 2022, v. 23, n. 5, p. 1, doi. 10.3892/ol.2022.13279

By:

FAROOQI, AMMAD AHMAD;
ZAHID, RABBIA;
NAUREEN, HUMAIRA;
ATTAR, RUKSET;
GAZOULI, MARIA;
BERARDI, ROSSANA;
SZELACHOWSKA, JOLANTA;
MATKOWSKI, RAFAŁ;
PAWLAK, EDYTA

Publication type:

Article

Excessive activation of IL-33/ST2 in cancer-associated fibroblasts promotes invasion and metastasis in ovarian cancer.

Published in:

Oncology Letters, 2022, v. 23, n. 5, p. 1, doi. 10.3892/ol.2022.13278

By:

CAIXIA FENG;
LI KOU;
PANYUE YIN;
YUAN JING

Publication type:

Article

miR-31-5p-DMD axis as a novel biomarker for predicting the development and prognosis of sporadic early-onset colorectal cancer.

Published in:

Oncology Letters, 2022, v. 23, n. 5, p. 1, doi. 10.3892/ol.2022.13277

By:

CHANGQIN LIU;
WEI WU;
WENJU CHANG;
RUIJIN WU;
XIAOMIN SUN;
HUILI WU;
ZHANJU LIU

Publication type:

Article

Role of kinesin family member 14 in disease monitoring and prognosis in patients with gastrointestinal cancer.

Published in:

Oncology Letters, 2022, v. 23, n. 5, p. 1, doi. 10.3892/ol.2022.13276

By:

PING CHEN;
WEINING FAN;
YUJIN HOU;
FANG WANG;
NA LUO

Publication type:

Article

NPTX1 inhibits pancreatic cancer cell proliferation and migration and enhances chemotherapy sensitivity by targeting RBM10.

Published in:

Oncology Letters, 2022, v. 23, n. 5, p. 1, doi. 10.3892/ol.2022.13275

By:

JING WU;
GAIFANG LIU;
KANG AN;
LINPING SHI

Publication type:

Article

Risk factors of perioperative complications and management with enhanced recovery after primary surgery in women with epithelial ovarian carcinoma in a single center.

Published in:

Oncology Letters, 2022, v. 23, n. 5, p. 1, doi. 10.3892/ol.2022.13274

By:

MIN LI;
TIANJIAO ZHANG;
JING ZHU;
YUEBO LI;
WENYING CHEN;
YANHU XIE;
WEI ZHANG;
RONGZHU CHEN;
WEI WEI;
GUIHONG WANG;
JIWEI QIN;
WEIDONG ZHAO;
DABAO WU;
ZHEN SHEN;
NASHAN, BJÖRN;
YING ZHOU

Publication type:

Article

Circular RNA 0001666 inhibits colorectal cancer cell proliferation, invasion and stemness by inactivating the Wnt/β-catenin signaling pathway and targeting microRNA-1229.

Published in:

Oncology Letters, 2022, v. 23, n. 5, p. 1, doi. 10.3892/ol.2022.13273

By:

FEI BAI;
CHAOHUI ZUO;
YONGZHONG OUYANG;
KE XIAO;
ZHUO HE;
ZHI YANG

Publication type:

Article

Effects of perioperative eicosapentaenoic acid-enriched oral nutritional supplement on the long-term oncological outcomes after total gastrectomy for gastric cancer.

Published in:

Oncology Letters, 2022, v. 23, n. 5, p. 1, doi. 10.3892/ol.2022.13272

By:

TORU AOYAMA;
TAKAKI YOSHIKAWA;
SATOSHI IDA;
HARUHIKO CHO;
KENTARO SAKAMAKI;
YUICHI ITO;
KAZUMASA FUJITANI;
NOBUHIRO TAKIGUCHI;
YOSHIYUKI KAWASHIMA;
KAZUHIRO NISHIKAWA;
SOYA NUNOBE;
NAOKI HIKI

Publication type:

Article

Radiotherapy plus cetuximab for locally advanced squamous cell head and neck cancer in patients with cisplatin-ineligible renal dysfunction: A retrospective study.

Published in:

Oncology Letters, 2022, v. 23, n. 5, p. 1, doi. 10.3892/ol.2022.13271

By:

CHIAKI IMAI;
HIROMI SAEKI;
KOHEI YAMAMOTO;
AYANO ICHIKAWA;
MAKOTO ARAI;
AKINOBU TAWADA;
TAKAAKI SUZUKI;
YUICHI TAKIGUCHI;
TOYOYUKI HANAZAWA;
ITSUKO ISHII

Publication type:

Article

Comprehensive analysis of competitive endogenous RNAs network: Identification and validation of prediction model composed of mRNA signature and miRNA signature in gastric cancer.

Published in:

Oncology Letters, 2022, v. 23, n. 5, p. 1, doi. 10.3892/ol.2022.13270

By:

WENSHUANG DING;
LIQIONG WU;
XIUBO LI;
LIJUN CHANG;
GUORONG LIU;
HONG DU

Publication type:

Article

MicroRNA-20a promotes non-small cell lung cancer proliferation by upregulating PD-L1 by targeting PTEN.

Published in:

Oncology Letters, 2022, v. 23, n. 5, p. 1, doi. 10.3892/ol.2022.13269

By:

JIAOMEI GONG;
YONG SHEN;
FUGUO JIANG;
YAN WANG;
LULU CHU;
JINQI SUN;
PENGXIAO SHEN;
MAOCAI CHEN

Publication type:

Article

miR-143-5p suppresses breast cancer progression by targeting the HIF-1a-related GLUT1 pathway.

Published in:

Oncology Letters, 2022, v. 23, n. 5, p. 1, doi. 10.3892/ol.2022.13268

By:

JIA XU;
XI LI;
PURONG ZHANG;
JIE LUO;
EXIAN MOU;
SHIWEI LIU

Publication type:

Article

Toxoplasma gondii causes changes in the host's expression of cancer-associated miRNAs.

Published in:

Oncology Letters, 2022, v. 23, n. 5, p. 1, doi. 10.3892/ol.2022.13267

By:

LIN WANG;
NING WANG;
YING HUI ZHAO;
GANG LU

Publication type:

Article

Expression of FOXM1 and PLK1 predicts prognosis of patients with hepatocellular carcinoma.

Published in:

Oncology Letters, 2022, v. 23, n. 5, p. 1, doi. 10.3892/ol.2022.13266

By:

WEIQIANG FAN;
HUAN MA;
BIN JIN

Publication type:

Article

Cadherin-16 inhibits thyroid carcinoma cell proliferation and invasion.

Published in:

Oncology Letters, 2022, v. 23, n. 5, p. 1, doi. 10.3892/ol.2022.13265

By:

XIAOLIN YANG;
YUKUN LI;
GELING LIU;
WEINA ZHA;
YING LIU

Publication type:

Article

Identification of potential circular RNA biomarkers in lung adenocarcinoma: A bioinformatics analysis and retrospective clinical study.

Published in:

Oncology Letters, 2022, v. 23, n. 5, p. 1, doi. 10.3892/ol.2022.13264

By:

YONGGANG ZHU;
FENG CAO;
FEI LIU;
SIHUA LIU;
LINGJIAO MENG;
LINA GU;
HANJUN ZHAO;
MEIXIANG SANG;
BAOEN SHAN

Publication type:

Article

Glycoprotein hormone a-subunit promotes cell proliferation and tumorigenesis in breast cancer.

Published in:

Oncology Letters, 2022, v. 23, n. 5, p. 1, doi. 10.3892/ol.2022.13263

By:

JUN ZHOU;
XUAN ZHU;
SHIJIE WU;
HUIHUI CHEN;
YIDING CHEN

Publication type:

Article

TPX2 regulated by miR-29c-3p induces cell proliferation in osteosarcoma via the AKT signaling pathway.

Published in:

Oncology Letters, 2022, v. 23, n. 5, p. 1, doi. 10.3892/ol.2022.13262

By:

DONGSHENG ZHU;
XIANGFEI XU;
MING ZHANG;
TONG WANG

Publication type:

Article

Management of chemotherapy dose intensity for metastatic colorectal cancer (Review).

Published in:

Oncology Letters, 2022, v. 23, n. 5, p. 1, doi. 10.3892/ol.2022.13261

By:

XUELEI CHU;
PENG XUE;
SHIJIE ZHU

Publication type:

Article

Upregulated phospholipase D2 expression and activity is related to the metastatic properties of melanoma.

Published in:

Oncology Letters, 2022, v. 23, n. 5, p. 1, doi. 10.3892/ol.2022.13260

By:

PEREZ-VALLE, ARANTZA;
OCHOA, BEGOÑA;
SHAH, KRUSHANGI N.;
BARREDA-GOMEZ, GABRIEL;
ASTIGARRAGA, EGOITZ;
BOYANO, MARÍA DOLORES;
ASUMENDI, AINTZANE

Publication type:

Article